Genix Pharmaceuticals Corp
XTSX:GENX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Addi Industries Ltd
BSE:507852
|
IN |
|
Southern Cross Media Group Ltd
ASX:SXL
|
AU |
|
L E Lundbergforetagen AB (publ)
STO:LUND B
|
SE |
Genix Pharmaceuticals Corp
Cash
Genix Pharmaceuticals Corp
Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
Cash
CA$13.3k
|
CAGR 3-Years
67%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-17%
|
|
|
Flora Growth Corp
NASDAQ:FLGC
|
Cash
$6m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
112%
|
CAGR 10-Years
N/A
|
|
|
Vitality Products Inc
XTSX:VPI
|
Cash
CA$144.2k
|
CAGR 3-Years
28%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Jamieson Wellness Inc
TSX:JWEL
|
Cash
CA$41.2m
|
CAGR 3-Years
16%
|
CAGR 5-Years
103%
|
CAGR 10-Years
N/A
|
|
|
L
|
Leef Brands Inc
CNSX:LEEF
|
Cash
$1.9m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genix Pharmaceuticals Corp
Glance View
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm focused on developing and licensing novels and products for sales through retail outlets and well as direct to consumers and e-commerce platforms. The firm holds licensing agreement for a range of products, including 30 Ophthalmic drugs, Sucanon, Renochlor, Flu-X, and Levothyroxine sodium (generic Synthroid). Flu-X anti-viral spray is an herbal, oral, anti-viral, anti-flu and anti-cold virus spray. Renochlor is an aid in the restoration of kidney health and kidney function. Sucanon is a natural substitute for prescription pharmaceuticals for non-insulin dependent diabetes patients.
See Also
What is Genix Pharmaceuticals Corp's Cash?
Cash
43.6k
CAD
Based on the financial report for Oct 31, 2025, Genix Pharmaceuticals Corp's Cash amounts to 43.6k CAD.
What is Genix Pharmaceuticals Corp's Cash growth rate?
Cash CAGR 10Y
-17%
Over the last year, the Cash growth was 279%. The average annual Cash growth rates for Genix Pharmaceuticals Corp have been 67% over the past three years , -43% over the past five years , and -17% over the past ten years .
